This is the first report showing that even as few as 50 EpCAM-positive live CTCs from metastatic prostate cancer patients can survive and grow in a xenograft assay, putatively containing metastasis-initiating-cells (MIC). The gene discussed is EPCAM; the disease is prostate carcinoma.